Although [detection bias] is a likely explanation, we cannot rule out that these are true increases in risk caused by the promotion of breast tumour growth by GLP-1 agonists, she says
Deng H, Yue JK, Zusman BE, Nwachuku EL, Abou-Al-Shaar H, Upadhyayula PS, et al
The GHRH component lowers the activation threshold of the somatotropic cells and makes them more receptive to the ghrelin-mediated stimulus
Companies prioritize high-margin sales to affluent, well-insured markets, aligning with shareholder interests rather than public health goals
"It can make it even harder to try and stick to healthy eating and avoiding those foods that we know aren't good for us." But the new GLP-1 injectable drugs can turn down the volume, allowing those battling obesity to change their relationship with food